Vitrolife extends the offer period in the offer for MediCult

With reference to the voluntary exchange offer (the "Offer") by Vitrolife AB (publ) (“Vitrolife”) to purchase the shares in MediCult a/s ("MediCult") (OSE: MEC), as set forth in the offer document of 3 February 2009 (the "Offer Document"), Vitrolife hereby announces an extension of the offer period under the Offer by two weeks.

Following such extension, the offer period will last until 11 March 2009 at 17:30 (CET).
All other dates referred to in the Offer Document will be extended accordingly. Vitrolife also reserves the right to make further extensions of the offer period, in accordance with the Offer Document section 1.5. Please see the Offer Document for further details.
The offer period is extended in order to give all existing shareholders in MediCult the possibility of thoroughly considering the Offer, and to allow for more time for discussions regarding a combination of MediCult and Vitrolife between the companies' respective management teams and boards of directors.


Contact persons
Contact persons at Vitrolife with respect to the Offer:
Patrik Tigerschiöld, Chairman of the Board tel. +46 707 77 71 90
Dr. Magnus Nilsson, CEO tel. +46 31 721 80 61